Resolute Onyx™ RONYX25012WRecalls & reported problems
Medtronic, Inc. · STENT RONYX25012W RESOLUTE ONYX 2.50X12 · Class 3 · Implant
All models of Resolute Onyx (101)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00643169602311), received between Jan 3, 2019 and Feb 13, 2024 — classified as 2 injuries, 3 malfunctions.
The most frequently reported specific device problem is “Leak/Splash” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Leak/Splash2
- Inflation Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Myocardial Infarction1
- No Consequences Or Impact To Patient1
- Occlusion1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionFeb 13, 2024Leak/Splash; Leak/Splash
AN ATTEMPT WAS MADE TO USE ONE RESOLUTE ONYX OTW CORONARY DRUG ELUTING STENT TO TREAT A MODERATELY CALCIFIED, MODERATELY TORTUOUS LESION WITH 80% STENOSIS IN THE MID RIGHT CORONARY ARTERY (RCA). THE DEVICE WAS NOT INSPECTED. NEGATIVE PREP WAS PERFORMED WITH NO ISSUES. THE LESION WAS NOT PRE-DILATED. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT. RESISTANCE WAS NOT ENCOUNTERED WHEN ADVANCING THE DEVICE. EXCESSIVE FORCE WAS NOT USED. IT WAS REPORTED THAT THERE WAS A SLOW LEAK. THE STENT WAS IMPLANTED. THE PATIENT IS ALIVE WITH NO INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18693324 ↗MalfunctionSep 19, 2022Leak/Splash; Leak/Splash
AN ATTEMPT WAS MADE TO USE ONE RESOLUTE ONYX OTW CORONARY DRUG ELUTING STENT (DES) TO TREAT A MODERATELY TORTUOUS, MODERATELY CALCIFIED LESION LOCATED IN THE MID LEFT ANTERIOR DESCENDING (LAD) ARTERY. THE DEVICE WAS INSPECTED PRIOR TO USE WITH NO ISSUES NOTED. NEGATIVE PREP WAS PERFORMED WITH NO ISSUES. THE LESION WAS NOT PRE-DILATED. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT. RESISTANCE WAS NOT ENCOUNTERED WHEN ADVANCING THE DEVICE EXCESSIVE FORCE WAS NOT USED. IT WAS REPORTED THAT WHEN THE BALLOON WAS INFLATED THERE WAS A SLOW DRIP OR LEAK AT THE TRANSITION OF THE CATHETER AND THE HUB. THE PATIENT IS REPORTED TO BE ALIVE WITH NO INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15445199 ↗InjuryJan 6, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING THE INDEX PROCEDURE A RESOLUTE ONYX DRUG ELUTING STENT WAS IMPLANTED IN THE RCA. IT WAS REPORTED THAT THE PATIENT SUFFERED A SPASM ON THE SAME DAY AS THE INDEX PROCEDURE. IT WAS REPORTED THAT THE VASOSPASM WAS NOT TREATED BUT CONSIDERED SIGNIFICANT BY INVESTIGATOR.
Patient problems: Occlusion
MAUDE report 9552497 ↗MalfunctionMar 28, 2019Inflation Problem; Inflation Problem
DURING A PROCEDURE AN ATTEMPT WAS MADE TO USE A RESOLUTE ONYX RX CORONARY DRUG ELUTING STENT TO TREAT A MILDLY TORTUOUS LESION LOCATED IN THE MID LEFT ANTERIOR DESCENDING (LAD) ARTERY. THE DEVICE WAS INSPECTED WITH NO ISSUES NOTED. THE LESION WAS NOT PRE-DILATED. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT. RESISTANCE WAS NOT ENCOUNTERED WHEN ADVANCING THE DEVICE AND EXCESSIVE FORCE WAS NOT USED DURING DELIVERY. IT WAS REPORTED THAT THERE WERE INFLATION DIFFICULTIES EXPERIENCED DURING STENT DEPLOYMENT WHILE INFLATING AT 12ATM. ANOTHER INFLATION DEVICE WAS USED TO ATTEMPT INFLATING THE DEVICE HOWEVER IT WOULD STILL NOT INFLATE. THE PROCEDURE WAS COMPLETED SUCCESSFULLY USING ANOTHER 2.50X12MM RESOLUTE ONYX STENT. THE PATIENT WAS REPORTED TO BE ALIVE WITH NO INJURY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8459437 ↗InjuryJan 3, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ONE RESOLUTE ONYX DRUG ELUTING STENT WAS IMPLANTED IN THE LAD IN A PATIENT. ONE DAY POST INDEX, ELEVATED ENZYMES WERE NOTED WHICH IS REPORTED TO BE RELATED TO MI, THE MI WAS IN A NON TARGET VESSEL. THE INVESTIGATOR ASSESSED THAT THE EVENT WAS NOT RELATED TO DEVICE OR TO THE ANTI PLATELET. PATIENT RECOVERED.
Patient problems: Myocardial Infarction
MAUDE report 8211802 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page